Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10519389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity

  1998cited by this paper
• Signal transduction through MAP kinase cascades.

  1998cited by this paper
• 14-3-3 Proteins Are Required for Maintenance of Raf-1 Phosphorylation and Kinase Activity

  1998cited by this paper
• The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338

  1998cited by this paper
• Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms

  1998cited by this paper
• Prostaglandin F2alpha stimulates tyrosine phosphorylation and mitogen-activated protein kinase in osteoblastic MC3T3-E1 cells via protein kinase C activation.

  1997cited by this paper
• Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro

  1997cited by this paper
• Regulation of Raf-1 kinase by interaction with the lipid second messenger, phosphatidic acid.

  1997cited by this paper
• Prostaglandin F2α Stimulates Tyrosine Phosphorylation and Mitogen-Activated Protein Kinase in Osteoblastic MC3T3-E1 Cells via Protein Kinase C Activation.

  1997cited by this paper
• The complexity of Raf-1 regulation.

  1997cited by this paper
• Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro.

  1996cited by this paper
• Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase.

  1996cited by this paper
• 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.

  1996cited by this paper
• Phospholipid antitumor agents

  1995cited by this paper
• Prostaglandin F2αStimulates Formation of p21ras-GTP Complex and Mitogen-activated Protein Kinase in NIH-3T3 Cells via Gq-protein-coupled Pathway (*)

  1995cited by this paper
• Advances in either phospholipids treatment of cancer.

  1995cited by this paper
• Prostaglandin F2α Receptor Is Coupled to Gq in cDNA-transfected Chinese Hamster Ovary Cells

  1994cited by this paper
• Cloning and expression of a cDNA for mouse prostaglandin F receptor.

  1994cited by this paper
• Activation of Raf as a result of recruitment to the plasma membrane.

  1994cited by this paper
• The ins and outs of Raf kinases.

  1994cited by this paper
• Prostaglandin F2 alpha receptor is coupled to Gq in cDNA-transfected Chinese hamster ovary cells.

  1994cited by this paper
• Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane

  1994cited by this paper
• The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex.

  1994cited by this paper
• Metabolism of alkyl lysophospholipid in epithelial cancer cell lines and inhibition of cell growth.

  1993cited by this paper
• Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.

  1992cited by this paper
• Membrane-interactive lipids as experimental anticancer drugs.

  1991cited by this paper
• Membrane-interactive lipids as experimental anticancer drugs.

  1991cited by this paper
• Mobilization of extracellular Ca2+ by prostaglandin F2 alpha can be modulated by fluoride in 3T3-L1 fibroblasts.

  1990cited by this paper
• Desensitization of prostaglandin F2 alpha-stimulated inositol phosphate generation in NIH-3T3 fibroblasts transformed by overexpression of normal c-Ha-ras-1, c-Ki-ras-2 and c-N-ras genes.

  1990cited by this paper
• Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

  1989cited by this paper
• Prostaglandin F2 alpha stimulates phosphatidylinositol 4,5-bisphosphate hydrolysis and mobilizes intracellular Ca2+ in bovine luteal cells.

  1987cited by this paper
• Methods for growth of cultured cells in serum-free medium.

  1980cited by this paper
• Growth of a human mammary tumour cell line in a serum-free medium

  1979cited by this paper
• Mobilization of extracellular Ca 2 + by prostaglandin F 2 , can be modulated by fluoride in 3 T 3L 1 fibroblasts

  year unknowncited by this paper

• Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs.

  2015cites this paper
• Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.

  2014cites this paper
• Glycosidated phospholipids - a promising group of anti-tumour lipids.

  2014cites this paper
• Structure–Activity Relationships of Glucosamine‐Derived Glycerolipids: the Role of the Anomeric Linkage, the Cationic Charge and the Glycero Moiety on the Antitumor Activity

  2013cites this paper
• Synthesis and biological evaluation of cyclopentane-linked alkyl phosphocholines as potential anticancer agents that act by inhibiting Akt phosphorylation.

  2012cites this paper
• Synthesis and Antitumor Activity of Ether Glycerophospholipids Bearing a Carbamate Moiety at the sn‐2 Position: Selective Sensitivity Against Prostate Cancer Cell Lines

  2010cites this paper
• Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane

  2010cites this paper
• A glycosylated antitumor ether lipid kills cells via paraptosis-like cell death.

  2009cites this paper
• Antitumour ether lipids: proapoptotic agents with multiple therapeutic indications

  2007cites this paper
• Cyclin B1 Is a Critical Target of RhoB in the Cell Suicide Program Triggered by Farnesyl Transferase Inhibition

  2004cites this paper
• The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.

  2003cites this paper
• Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.

  2003cites this paper
• Geranylgeranylated RhoB Mediates the Apoptotic and Antineoplastic Effects of Farnesyltransferase Inhibitors

  2002cites this paper
• Synthesis and antiproliferative properties of a photoactivatable analogue of ET-18-OCH 3

  2001cites this paper
• Actin' up: RhoB in cancer and apoptosis

  2001cites this paper
• Farnesyltransferase inhibitors: mechanism and applications

  2001cites this paper
• Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects.

  2000cites this paper
• RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors

  2000cites this paper
• Geranylgeranylated RhoB is sufficient to mediate tissue‐specific suppression of Akt kinase activity by farnesyltransferase inhibitors

  2000cites this paper